课题基金 / 基金详情

Corepressors for the Orphan Receptor RevErb

Corepressors for the Orphan Receptor RevErb
孤儿受体 RevErb 的辅阻遏物
批准号:
6541120
负责人:
MITCHELL A. LAZAR
金额:
$39.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2007-03-31

项目摘要

项目成果

MITCHELL A. LAZAR的其他基金

相似基金

相关文献

中文摘要
翻译
核激素受体(NRs)是细胞生长、分化和代谢的关键转录调节因子。 NR超家族包括激素、维生素、代谢物和外源性物质的受体,以及没有已知配体的受体,称为孤儿受体,NR通过募集共阻遏物N-CoR和SMRT来在不存在配体的情况下抑制转录。 激素作用主要是辅阻遏物解离的结果,伴随着辅激活物分子的募集。 该实验室的主要目标是了解从核受体与辅阻遏物的相互作用到阻遏信号的分子介质的转录阻遏。 孤儿受体RevErb是一种极好的核受体,具有抑制信号的分子介质的共阻遏物。 孤儿受体RevErb是研究激活螺旋的极好模型,RevErb同源二聚体将N-CoR募集到特定的DNA结合位点。 我们假设,每个亚基的DNA结合的RevErb同源二聚体结合到一个特定的DNA结合位点。 我们假设,每个亚基的DNA结合的RevErb同源二聚体结合到一个不同的CoRNR基序在N-CoR。 该假设将在特异性目标1中进行直接测试,其将使用诱变、嵌合受体和共阻遏物以及蛋白水解图谱确定RevErb同源二聚体与共阻遏物相互作用的分子机制。 我们还鉴定了多种组蛋白脱乙酰酶(HDAC)和其他与N-CoR/SMRT相互作用的蛋白质,它们是抑制信号的潜在介质。我们假设不同的共阻遏物和共阻遏物相关蛋白被RevErb和其他NR以受体和细胞特异性方式招募。 具体目标2是使用染色质免疫沉淀和RNA干扰来确定参与RevErb和其他NR体内阻遏的共阻遏物和共阻遏物相关蛋白。 我们还表明,N-CoR和SMRT作为HDAC 3酶的激活辅因子。具体目标3是确定这种现象的机制,并了解其对其他辅阻遏物和其他HDAC的适用性。 我们推测SMRT和N-CoR还具有与染色质修饰和转录抑制相关的其他功能。初步数据表明,这样的功能之一是组蛋白结合。具体目标4是了解辅阻遏物的染色质相关功能。 阐明组蛋白结合的机制和功能。 总之,这些研究将阐明NR与辅阻遏物相互作用的调节以及辅阻遏物对转录的调节的基本机制。 从这项工作中获得的见解将扩大我们对激素作用机制的理解,并有可能导致与NR功能相关的疾病的新方法,包括肥胖症,糖尿病和白血病。
英文摘要
Nuclear hormone receptors (NRs) are key transcriptional regulators of cellular growth, differentiation, and metabolism. The NR superfamily include receptors for hormones, vitamins, metabolites, and xenobiotics, as well as receptors without known ligands, termed orphan receptors, NRs repress transcription in the absence of ligand by recruiting co-repressors N-CoR and SMRT. Hormone action is largely the result of dissociation of co-repressor, accompanied by the recruitment of co-activator molecules. A major goal of this laboratory is to understand transcriptional repression from the interaction of NRs with the co-repressors to the molecular mediators of the repressive signal. The orphan receptor RevErb has been a superb of NRs with co-repressors to the molecular mediators of the repressive signal. The orphan receptor RevErb has been a superb model for learning about activation helix, and that RevErb homodimers recruit N-CoR to specific DNA binding sites. We hypothesize that each subunit of the DNA-bound RevErb homodimer binds to a specific DNA binding sites. We hypothesize that each subunit of the DNA-bound RevErb homodimer binds to a different CoRNR motif in N-CoR. This hypothesis will be directed tested in Specific Aim 1, which will determine the molecular mechanism by which RevErb homodimers interact with co-repressor using mutagenesis, chimeric receptors and co-repressors, and proteolytic mapping. We have also identified multiple histone deacetylases (HDACs) and other proteins that interact with N-CoR/SMRT and are potential mediators of the repressive signal. We hypothesize that different co-repressors and co-repressor associated proteins are recruited by RevErb and other NRs in a receptor- and cell-specific manner. Specific Aim 2 is to determine the co-repressors and co-repressor-associated proteins involved in repression by RevErb and other NRs in vivo, using chromatin immunoprecipitation and RNA interference. We have also shown that N-CoR and SMRT act as activ ating co-factors for the HDAC3 enzyme. Specific Aim 3 is to determine the mechanism of this phenomenon, and to understand its applicability to other co-repressors and other HDACs. We hypothesize that SMRT and N-CoR have others functions related to chromatin modification and transcriptional repression. Preliminary data indicate that one such function is histone binding. Specific Aim 4 is to understand the chromatin-related function of the co-repressors. The mechanism and function of histone binding will be elucidated. Together, these studies will elucidate basic mechanisms underlying the regulation of NR interactions with co-repressors, and co-repressor regulation of transcription. The insights gained from this work will expand our understanding of the mechanisms of hormone action, and has potential to lead to novel approaches to diseases associated with NR function, including obesity, diabetes, and leukemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
  • 批准号:
    10210669
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2021
  • 负责人:
    MITCHELL A. LAZAR
  • 依托单位:
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
  • 批准号:
    10372221
  • 项目类别:
  • 资助金额:
    $35.75万
  • 财政年份:
    2021
  • 负责人:
    MITCHELL A. LAZAR
  • 依托单位:
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
  • 批准号:
    10576286
  • 项目类别:
  • 资助金额:
    $35.75万
  • 财政年份:
    2021
  • 负责人:
    MITCHELL A. LAZAR
  • 依托单位:
Thyroid hormone receptors - regulation and function
  • 批准号:
    8010993
  • 项目类别:
  • 资助金额:
    $9.95万
  • 财政年份:
    2010
  • 负责人:
    MITCHELL A. LAZAR
  • 依托单位:
海外基金